ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 180,78
0,46%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. MEI Pharma Inc (MEIP)

  7. MEI Pharma Inc (MEIP) Actualités

MEIP MEI Pharma Inc

3,06
0,00 (0,00%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
MEI Pharma Inc MEIP NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 3,06 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,13 3,06 3,21 3,06 3,06
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
11/4/202414:02BWMEI Pharma Board of Directors Aligns on Strategy to Advance..
11/4/202414:00BWMEI Pharma Reports Initial Data from Clinical Study..
10/4/202414:00BWMEI Pharma to Present at the Stifel 2024 Virtual Targeted..
26/3/202413:00BWMEI Pharma Reports Update from Clinical Study Evaluating..
29/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
21/2/202422:00EDGAR2Form 8-K - Current report
20/2/202423:33EDGAR2Form S-3 - Registration statement under Securities Act of..
13/2/202423:05EDGAR2Form 8-K - Current report
13/2/202423:05BWMEI Pharma Reports Second Quarter Fiscal Year 2024 Results..
17/1/202422:00EDGAR2Form 8-K - Current report
16/1/202423:00BWMEI Pharma to Present Design of Ongoing Clinical Study..
26/12/202323:00EDGAR2Form 8-K - Current report
22/12/202322:00EDGAR2Form 8-K - Current report
21/12/202303:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202303:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202322:00EDGAR2Form 8-K - Current report
11/12/202322:00EDGAR2Form 8-K - Current report
11/12/202318:00BWMEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor..
15/11/202302:59EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/11/202322:06EDGAR2Form 8-K - Current report
09/11/202322:05BWMEI Pharma Reports First Quarter Fiscal Year 2024 Results..
09/11/202322:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202323:03EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/11/202323:02EDGAR2Form DEF 14A - Other definitive proxy statements
08/11/202314:00BWMEI Pharma to Present at the Stifel 2023 Healthcare..
06/11/202322:57BWMEI Pharma Declares Special Cash Dividend of $1.75 Per Share..
03/11/202323:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/11/202314:00BWMEI Pharma Announces Acceptance of Abstract for Presentation..
01/11/202322:20EDGAR2Form SC 13D/A - General statement of acquisition of..
01/11/202322:15EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
01/11/202321:54EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
01/11/202321:01EDGAR2Form 8-K - Current report
01/11/202314:00BWMEI Pharma Enters into Agreement with Anson Funds and Cable..
27/10/202322:05EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
25/10/202301:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/10/202301:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202323:00EDGAR2Form SC 13D/A - General statement of acquisition of..
17/10/202323:33BWMEI Pharma Recommends Stockholders Not to Consent
17/10/202323:28EDGAR2Form DEFC14A - Definitive proxy statement, contested..
13/10/202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202323:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202323:00EDGAR2Form SC 13D/A - General statement of acquisition of..
13/10/202301:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202301:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202301:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202301:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202301:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202323:25EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
10/10/202321:00EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
10/10/202316:33EDGAR2Form DEFC14A - Definitive proxy statement, contested..

Dernières Valeurs Consultées

NASDAQ
MEIP
MEI Pharma
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés